FOLH1 and metastatic prostate carcinoma: Nevertheless, given that the initial 18F-FDG PET/CT findings were sufficient for the diagnosis of metastatic prostate cancer and economic factors were taken into account, the patient did not undergo additional PSMA PET/CT imaging.